Is reduction of viral fitness a valid antiviral approach

作者: Massimo Clementi , Roberto Burioni

DOI: 10.1016/J.DDSTR.2007.12.001

关键词: RNARecombinant DNAViral replicationViral pathogenesisVirologyBiologyAdaptationMonoclonal antibodyVirusViral evolution

摘要: Viral fitness, the replicative adaptation of a virus to its environment, has viral and environmental determinants. Presently, growth competition assays recombinant viruses can supply precise evaluation this parameter potential clinical interest. On basis data obtained by monitoring infections under treatment with antiviral compounds sequence-function analysis drug-resistant variants, it recently been proposed that intentional selection mutants reduced fitness could be an efficient strategy in several important humans. From point view, specific as well human monoclonal antibodies targeting crucial proteins effective modifying replication capacity pathogenic rapidly evolving RNA are normally able escape pressure treatments single or multiple drugs.

参考文章(64)
J P Routy, M A Wainberg, M Petrella, B G Brenner, D Turner, Rationale for maintenance of the M184v resistance mutation in human immunodeficiency virus type 1 reverse transcriptase in treatment experienced patients. New Microbiologica. ,vol. 27, pp. 31- 39 ,(2004)
John J. Holland, Esteban Domingo, Juan Carlos de la Torre, David A. Steinhauer, Mutation frequencies at defined single codon sites in vesicular stomatitis virus and poliovirus can be increased only slightly by chemical mutagenesis. Journal of Virology. ,vol. 64, pp. 3960- 3962 ,(1990) , 10.1128/JVI.64.8.3960-3962.1990
François Clavel, Esther Race, Fabrizio Mammano, HIV drug resistance and viral fitness. Advances in pharmacology (San Diego). ,vol. 49, pp. 41- 66 ,(2000) , 10.1016/S1054-3589(00)49023-X
O Narayan, J E Clements, D E Griffin, J S Wolinsky, Neutralizing antibody spectrum determines the antigenic profiles of emerging mutants of visna virus Infection and Immunity. ,vol. 32, pp. 1045- 1050 ,(1981) , 10.1128/IAI.32.3.1045-1050.1981
X TONG, R CHASE, A SKELTON, T CHEN, J WRIGHTMINOGUE, B MALCOLM, Identification and analysis of fitness of resistance mutations against the HCV protease inhibitor SCH 503034. Antiviral Research. ,vol. 70, pp. 28- 38 ,(2006) , 10.1016/J.ANTIVIRAL.2005.12.003
A. Weiner, A. L. Erickson, J. Kansopon, K. Crawford, E. Muchmore, A. L. Hughes, M. Houghton, C. M. Walker, Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 92, pp. 2755- 2759 ,(1995) , 10.1073/PNAS.92.7.2755
Maiken Arendrup, Claus Nielsen, John-Erik Stig Hansen, Court Pedersen, Lars Mathiesen, Jens Ole Nielsen, Autologous HIV-1 neutralizing antibodies: emergence of neutralization-resistant escape virus and subsequent development of escape virus neutralizing antibodies. Journal of Acquired Immune Deficiency Syndromes. ,vol. 5, pp. 303- 307 ,(1992) , 10.1097/00126334-199203000-00012
R Namikawa, H Kaneshima, M Lieberman, I. Weissman, J. McCune, Infection of the SCID-hu mouse by HIV-1 Science. ,vol. 242, pp. 1684- 1686 ,(1988) , 10.1126/SCIENCE.3201256
L. A. Loeb, J. M. Essigmann, F. Kazazi, J. Zhang, K. D. Rose, J. I. Mullins, Lethal mutagenesis of HIV with mutagenic nucleoside analogs. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 96, pp. 1492- 1497 ,(1999) , 10.1073/PNAS.96.4.1492
M. Eigen, Error catastrophe and antiviral strategy Proceedings of the National Academy of Sciences of the United States of America. ,vol. 99, pp. 13374- 13376 ,(2002) , 10.1073/PNAS.212514799